You have 9 free searches left this month | to do more
Showing 1 - 9 of
9 items
Did you mean:
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Active, not recruiting
  • Hodgkin Disease
  • Lymphoma, Large-cell, Anaplastic
    • Astrakhan, Russian Federation
    • +14 more
    2021-02-22
    Feb 22, 2021
    M
    Active, not recruiting
    • Anaplastic Large-cell Lymphoma
    • brentuximab vedotin
    • Antwerpen, Belgium
    • +39 more
    2021-09-30
    Sep 30, 2021
    T
    Recruiting
    • Hodgkin Disease
    • Lymphoma, T-Cell, Cutaneous
    • No Intervention
    • San Bartolome, Alicante, Spain
    • +29 more
    2021-11-04
    Nov 4, 2021
    T
    Completed
    • Hodgkin Disease
    • Lymphoma, Large-Cell, Anaplastic
    • Brentuximab Vedotin
    • Beijing, Beijing, China
    • +6 more
    2021-02-03
    Feb 3, 2021
    I
    Recruiting
    • Enteropathy Associated T-cell Lymphoma
    • Brentuximab Vedotin
    • Paris, France
      Hopital Necker - Enfants malades
    2021-02-09
    Feb 9, 2021
    S
    Recruiting
    • Hodgkin Lymphoma
    • +2 more
    • brentuximab vedotin
    • Anaheim, California
    • +18 more
    2021-12-10
    Dec 10, 2021
    S
    Recruiting
    • Peripheral T-cell Lymphoma
    • brentuximab vedotin
    • +3 more
    • Birmingham, Alabama
    • +36 more
    2022-01-07
    Jan 7, 2022
    M
    Completed
    • Relapsed or Refractory Hodgkin Lymphoma
    • Relapsed or Refractory Anaplastic Large-cell Lymphoma
    • Brentuximab vedotin
    • Aurora, Colorado
    • +17 more
    2018-11-12
    Nov 12, 2018
    M
    Completed
    • Hodgkin Lymphoma
    • Anaplastic Large-cell Lymphoma
    • brentuximab vedotin
    • Brentuximab vedotin and rifampicin
    • Brussels, Belgium
    • +5 more
    2016-03-30
    Mar 30, 2016